Zeller W J, Schmähl D
Arzneimittelforschung. 1978;28(9):1564-6.
Monotherapy of early rat leukemia L 5222 with 5 X 100 mg/kg EDU over 48 h yielded no increase in lifespan as compared to untreated controls. Combination therapy of advanced L 5222 with EDU and CPA in four different schedules results in no increase in life-span as compared to treatment with CPA only. DNA histogrms of preterminal L 5222 revealed no synchronizing effect of EDU.
早期大鼠白血病L 5222在48小时内以5×100毫克/千克的EDU进行单一疗法,与未治疗的对照组相比,寿命没有增加。晚期L 5222采用EDU和CPA进行四种不同方案的联合治疗,与仅用CPA治疗相比,寿命没有增加。终末期前L 5222的DNA直方图显示EDU没有同步作用。